Guardian Pharmacy Services (NYSE:GRDN) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Guardian Pharmacy Services (NYSE:GRDN) from a hold rating to a buy rating in a report published on Sunday morning.

Several other equities analysts have also issued reports on GRDN. Truist Financial boosted their price target on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Oppenheimer raised their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday. Bank of America lifted their price objective on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, August 6th. Finally, Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $43.83.

Guardian Pharmacy Services Trading Down 5.1%

GRDN stock opened at $39.35 on Friday. The firm has a market cap of $1.96 billion, a PE ratio of 38.20, a price-to-earnings-growth ratio of 2.17 and a beta of 0.10. The stock has a 50-day moving average price of $40.96 and a 200-day moving average price of $37.32. Guardian Pharmacy Services has a 1-year low of $19.30 and a 1-year high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The company had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. On average, analysts forecast that Guardian Pharmacy Services will post 1.18 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Great Lakes Advisors LLC acquired a new stake in Guardian Pharmacy Services in the second quarter valued at approximately $788,000. Handelsbanken Fonder AB bought a new stake in shares of Guardian Pharmacy Services during the second quarter valued at approximately $511,000. Bank of America Corp DE raised its position in shares of Guardian Pharmacy Services by 86.1% during the first quarter. Bank of America Corp DE now owns 128,048 shares of the company’s stock worth $4,822,000 after purchasing an additional 59,245 shares during the period. The Manufacturers Life Insurance Company raised its position in shares of Guardian Pharmacy Services by 67.4% during the first quarter. The Manufacturers Life Insurance Company now owns 11,820 shares of the company’s stock worth $445,000 after purchasing an additional 4,761 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Guardian Pharmacy Services by 79.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 38,185 shares of the company’s stock worth $1,438,000 after purchasing an additional 16,866 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.